328 related articles for article (PubMed ID: 26464846)
1. Biomarkers in Exhaled Breath Condensate and Serum of Chronic Obstructive Pulmonary Disease and Non-Small-Cell Lung Cancer.
Lim MY; Thomas PS
Int J Chronic Dis; 2013; 2013():578613. PubMed ID: 26464846
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.
Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X
Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787
[TBL] [Abstract][Full Text] [Related]
3. Exhaled breath condensate biomarkers in COPD.
Borrill ZL; Roy K; Singh D
Eur Respir J; 2008 Aug; 32(2):472-86. PubMed ID: 18669788
[TBL] [Abstract][Full Text] [Related]
4. Breath condensate nitrite correlates with hyperinflation in chronic obstructive pulmonary disease.
Gessner C; Hammerschmidt S; Kuhn H; Hoheisel G; Gillissen A; Sack U; Wirtz H
Respir Med; 2007 Nov; 101(11):2271-8. PubMed ID: 17693071
[TBL] [Abstract][Full Text] [Related]
5. Correlation Between Tumor Necrosis Factor-α and Interleukin-1β in Exhaled Breath Condensate and Pulmonary Function.
Lin X; Fan Y; Wang X; Chi M; Li X; Zhang X; Sun D
Am J Med Sci; 2017 Oct; 354(4):388-394. PubMed ID: 29078843
[TBL] [Abstract][Full Text] [Related]
6. Clinical value of exhaled breath condensate let-7 in non-small cell lung cancer.
Chen JL; Han HN; Lv XD; Ma H; Wu JN; Chen JR
Int J Clin Exp Pathol; 2020; 13(2):163-171. PubMed ID: 32211096
[TBL] [Abstract][Full Text] [Related]
7. Proteomics of exhaled breath condensate in stable COPD and non-COPD controls using tandem mass tags (TMTs) quantitative mass spectrometry: A pilot study.
Sun C; Zhou T; Xie G; Fu S; Gao L; Liao J; Wu Y; Wang G
J Proteomics; 2019 Aug; 206():103392. PubMed ID: 31129269
[TBL] [Abstract][Full Text] [Related]
8. Study of mitochondrial DNA alteration in the exhaled breath condensate of patients affected by obstructive lung diseases.
Carpagnano GE; Lacedonia D; Carone M; Soccio P; Cotugno G; Palmiotti GA; Scioscia G; Foschino Barbaro MP
J Breath Res; 2016 Apr; 10(2):026005. PubMed ID: 27063576
[TBL] [Abstract][Full Text] [Related]
9. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review.
Kubáň P; Foret F
Anal Chim Acta; 2013 Dec; 805():1-18. PubMed ID: 24296139
[TBL] [Abstract][Full Text] [Related]
10. Discriminative potential of exhaled breath condensate biomarkers with respect to chronic obstructive pulmonary disease.
Freund R; Sauvain JJ; Suarez G; Wild P; Charreau T; Debatisse A; Sakthithasan K; Jouannique V; Pralong JA; Guseva Canu I
J Occup Med Toxicol; 2024 Apr; 19(1):10. PubMed ID: 38576000
[TBL] [Abstract][Full Text] [Related]
11. Biomarkers of some pulmonary diseases in exhaled breath.
Kharitonov SA; Barnes PJ
Biomarkers; 2002; 7(1):1-32. PubMed ID: 12101782
[TBL] [Abstract][Full Text] [Related]
12. Epidermal Growth Factor in Exhaled Breath Condensate as Diagnostic Method for Non-Small Cell Lung Cancer.
Chen J; Chen J; Lv X; Yang Q; Yao S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819872271. PubMed ID: 31495334
[TBL] [Abstract][Full Text] [Related]
13. Malondialdehyde and 3-nitrotyrosine in exhaled breath condensate in retired elderly coal miners with chronic obstructive pulmonary disease.
Lee JS; Shin JH; Hwang JH; Baek JE; Choi BS
Saf Health Work; 2014 Jun; 5(2):91-6. PubMed ID: 25180140
[TBL] [Abstract][Full Text] [Related]
14. Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors.
Bikov A; Lazar Z; Gyulai N; Szentkereszty M; Losonczy G; Horvath I; Galffy G
Lung; 2015 Dec; 193(6):957-63. PubMed ID: 26260979
[TBL] [Abstract][Full Text] [Related]
15. Mass Spectrometry Analysis of the Exhaled Breath Condensate and Proposal of Dermcidin and S100A9 as Possible Markers for Lung Cancer Prognosis.
Núñez-Naveira L; Mariñas-Pardo LA; Montero-Martínez C
Lung; 2019 Aug; 197(4):523-531. PubMed ID: 31115649
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory mediators in exhaled breath condensate and peripheral blood of healthy donors and stable COPD patients.
Hao W; Li M; Zhang C; Zhang Y; Wang P
Immunopharmacol Immunotoxicol; 2019 Apr; 41(2):224-230. PubMed ID: 31046512
[No Abstract] [Full Text] [Related]
17. [Assessment of airway inflammation in chronic obstructive pulmonary disease: biomarkers in exhaled breath condensate].
Antus B
Orv Hetil; 2012 Jun; 153(22):843-51. PubMed ID: 22641258
[TBL] [Abstract][Full Text] [Related]
18. Angiogenic markers in breath condensate identify non-small cell lung cancer.
Gessner C; Rechner B; Hammerschmidt S; Kuhn H; Hoheisel G; Sack U; Ruschpler P; Wirtz H
Lung Cancer; 2010 May; 68(2):177-84. PubMed ID: 19647334
[TBL] [Abstract][Full Text] [Related]
19. Non-invasive methods to assess biomarkers of exposure and early stage of pulmonary disease in smoking subjects.
Malerba M; Ragnoli B; Corradi M
Monaldi Arch Chest Dis; 2008 Sep; 69(3):128-33. PubMed ID: 19065847
[TBL] [Abstract][Full Text] [Related]
20. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
